Biomx Inc Stock In The News
| PHGE Stock | USD 0.55 0.01 1.85% |
Our overall analysis of Biomx's news coverage and content from conventional and social sources shows investors' bearish mood towards Biomx Inc. The specific impact of Biomx news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Biomx's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Biomx headlines in addition to utilizing other, more conventional financial analysis modules. Check out Biomx Backtesting and Biomx Hype Analysis.
Biomx |
Biomx Today Top News and Investor Outlook
Biomx Inc Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Biomx and other traded companies coverage with news coverage. We help investors stay connected with Biomx headlines for the 26th of November to make an informed investment decision based on correlating the impacts of news items on Biomx Stock performance. Please note that trading solely based on the Biomx Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.
Biomx stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Biomx earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Biomx that are available to investors today. That information is available publicly through Biomx media outlets and privately through word of mouth or via Biomx internal channels. However, regardless of the origin, that massive amount of Biomx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biomx news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biomx relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biomx's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biomx alpha.
Biomx Largest EPS Surprises
Earnings surprises can significantly impact Biomx's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-11-14 | 2023-09-30 | -0.115 | -0.13 | -0.015 | 13 | ||
2022-05-11 | 2022-03-31 | -0.3 | -0.27 | 0.03 | 10 | ||
2023-03-29 | 2022-12-31 | -0.2367 | -0.2 | 0.0367 | 15 | ||
2020-05-14 | 2020-03-31 | -0.22 | -0.26 | -0.04 | 18 | ||
2021-08-16 | 2021-06-30 | -0.345 | -0.3 | 0.045 | 13 | ||
2021-11-15 | 2021-09-30 | -0.305 | -0.37 | -0.065 | 21 |
Biomx Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Biomx Inc Stock. Current markets are strongly bearish. About 75% of major world exchanges and indexes are down. See today's market update for more information.
25th of November 2024
Immix Biopharma Presents Positive NXC-201 Clinical Data at 66th American Society of Hemato... at gurufocus.com
20th of November 2024
BiomX 5-Day RSI 13.43 - GuruFocus.com at news.google.com
18th of November 2024
CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual... at accesswire.com
15th of November 2024
Anson Funds Management LP Acquires New Stake in ZyVersa Therapeutics Inc at gurufocus.com
14th of November 2024
Earnings call BiomX reports Q3 2024 financials, updates on clinical trials at investing.com
14th of November 2024
ARMISTICE CAPITAL, LLC Acquires New Stake in CNS Pharmaceuticals Inc - GuruFocus.com at news.google.com
12th of November 2024
Sonnet BioTherapeutics Releases Virtual Investor What this Means Segment at globenewswire.com
6th of November 2024
Sonnet BioTherapeutics Announces Pricing of 5.0 Million Underwritten Public Offering Price... at finance.yahoo.com
5th of November 2024
ZyVersa Therapeutics Highlights Published Data Demonstrating the Potential of Inflammasome... at finance.yahoo.com
15th of October 2024
BiomX Announces a Mandatory Unit Separation at globenewswire.com
7th of October 2024
ZyVersa Therapeutics Forms New Scientific Advisory Board to Support Development of Inflamm... at globenewswire.com
4th of October 2024
Acquisition by Orbimed Israel Biofund Gp Limited Partnership of 1789959 shares of Biomx at... at Orbimed Israel Biofund Gp Limited Partnership
19th of September 2024
Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis E... at finance.yahoo.com
18th of September 2024
BiomX to Provide Latest Update on Positive Phase 1b2a Clinical Trial Data for BX004 at the... at globenewswire.com
16th of September 2024
Acquisition by Assaf Oron of 25804 shares of Biomx subject to Rule 16b-3 at Assaf Oron
3rd of September 2024
IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS ... at finance.yahoo.com
20th of August 2024
Were Not Very Worried About ARCA biopharmas Cash Burn Rate at finance.yahoo.com
16th of August 2024
Acquisition by Janus Henderson Group Plc of 5390 shares of ARCA Biopharma at 2.93 subject ... at seekingalpha.com
9th of July 2024
Acquisition by Janus Henderson Group Plc of 16917 shares of ARCA Biopharma at 3.43 subject... at news.google.com
24th of June 2024
Dow Jumps 300 Points Alimera Sciences Shares Spike Higher at benzinga.com
24th of May 2024
YS Biopharma to change legal name to LakeShore Biopharma at seekingalpha.com
20th of May 2024
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investiga... at globenewswire.com
10th of May 2024
EFTR Stock Earnings eFFECTOR Therapeutics Meets EPS for Q1 2024 at investorplace.com
22nd of April 2024
Head to Head Survey eFFECTOR Therapeutics versus COMPASS Pathways - Defense World at news.google.com
6th of July 2023
Curis takes aim at late-stage trials as FDA lifts final hold on leukemia ... - FierceBiote... at news.google.com
30th of June 2023
Kiromic Biopharma Shares Down 12 percent After Stock Offering Prospectus at marketwatch.com
23rd of June 2023
Payment of 4504 shares by William Duke of Apexigen subject to Rule 16b-3 at MacroaxisInsider
1st of June 2023
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split at finance.yahoo.com
31st of May 2023
Head-To-Head Contrast Brookline Capital Acquisition and Compugen at thelincolnianonline.com
25th of May 2023
Landos Biopharma Announces 1-for-10 Reverse Stock Split at globenewswire.com
25th of May 2023
Acquisition by William Duke of 150000 shares of Apexigen subject to Rule 16b-3 at zacks.com
16th of May 2023
Should You Hold Kiromic Biopharma Inc Stock Tuesday Morning - InvestorsObserver at news.google.com
3rd of May 2023
Kiromic BioPharma, Inc. Sees Large Increase in Short Interest at thelincolnianonline.com
14th of March 2023
SHAREHOLDER NOTICE Halper Sadeh LLC Investigates DSEY, FRBA, MLVF, ANGN at prnewswire.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biomx in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biomx's short interest history, or implied volatility extrapolated from Biomx options trading.
Check out Biomx Backtesting and Biomx Hype Analysis. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomx. If investors know Biomx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.26) | Return On Assets (0.33) | Return On Equity (1.21) |
The market value of Biomx Inc is measured differently than its book value, which is the value of Biomx that is recorded on the company's balance sheet. Investors also form their own opinion of Biomx's value that differs from its market value or its book value, called intrinsic value, which is Biomx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomx's market value can be influenced by many factors that don't directly affect Biomx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.